Abstract
Elevated Donor-Derived Cell-Free DNA (dd-cfDNA) in the Early Post-Transplant Period Is Associated With an Increased Incidence of Adverse Clinical Outcomes in Kidney Transplant Recipients
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have